Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.
Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Location: United States, California, Redwood City
Employees: 11-50
Total raised: $85M
Investors 2
| Date | Name | Website |
| - | Avego | avego.com |
| - | Abingworth... | abingworth... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.01.2020 | Series A | $50M | - |
| 09.12.2019 | Series A | $35M | Abingworth... |
Mentions in press and media 5
| Date | Title | Description |
| 06.02.2024 | Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock | - |
| 09.01.2020 | Jasper Therapeutics Announces Expansion of Series A Financing, Bringing Total Corporate Fundraising to More than $50 Million | - |
| 09.01.2020 | Jasper Therapeutics Raises Additional $14.1M in Series A Financing | Jasper Therapeutics, Inc., a Palo Alto, Calif.-based biotechnology company focused on hematopoietic cell transplant therapies, expanded its Series A financing with an additional investment of $14.1m. The round was led by Roche Venture Fund ... |
| 09.12.2019 | Jasper Therapeutics Launches with $35M Series A | PALO ALTO, CA, Jasper Therapeutics announced the launch of the company with a $35 million total Series A financing. >> Click here for more funding data on Jasper Therapeutics >> To export Jasper Therapeutics funding data to ... |
| 07.12.2019 | Jasper Therapeutics Raises $35M in Series A Financing | Jasper Therapeutics, Inc., a Palo Alto, Calif.-based new biotechnology company, raised $35m in Series A financing. The round was led by Abingworth LLP and Qiming Venture Partners USA with further investment from Surveyor Capital (a Citadel ... |